PINAR OBAKAN, ŞEYMA YILDIRIM, MERT BURAK ÖZTÜRK, ÖZGE BERRAK, AJDA ÇOKER GÜRKAN, ELİF DAMLA ARISAN, ZEYNEP NARÇİN ÜNSAL

CDK inhibitors-induced SSAT expression requires NF?B and PPAR? inMCF-7 breast cancer cells

The cyclin-dependent kinase (CDK) inhibitors purvalanol and roscovitine are therapeutic agents that control cell proliferation through regulating cell-cycle machinery. They also affect polyamine (PA) metabolism, which is activated in malignant tissues. Therefore, PA catabolism became a remarkable target in cancer therapies. Induction of the PA catabolic enzyme spermidine/spermine N1-acetyltransferase (SSAT) is under the control of transcription factors such as NF?B and PPARγ. The purpose of this study was to investigate the therapeutic potential of CDK inhibitors in combination with PAs in MCF-7 breast cancer cells. In order to understand the involvement of PA catabolic enzyme SSAT in this process we also checked its transcriptional regulation in the presence of CDK inhibitors. MCF-7 cells were exposed to CDK inhibitors in the absence or presence of Spd and Spm. Cell viability loss was evaluated by MTT assay. Apoptosis was determined by annexin-V/PI staining using FACS flow. The SSAT transcription level was measured by qRT-PCR. Intracellular PA pool was determined by HPLC. Protein expressions were assessed by western blotting. We found that CDK inhibitors decreased cell viability in a time-dependent manner and induced apoptosis. Co-treatment of Spd or Spm with CDK inhibitors prevented the apoptotic potential of both drugs. Purvalanol increased SSAT expression levels in a time-dependent manner. Although the induction of SSAT by purvalanol resulted in the activation of NF?B at early time points, induction was accomplished by PPARγ as a late response after purvalanol treatment. We concluded that both transcriptional control mechanisms could be responsible for SSAT regulation in a time-dependent manner.

Anahtar Kelimeler:

Polyamines, SSAT, purvalanol, PPAR?, NF?B

CDK inhibitors-induced SSAT expression requires NF?B and PPAR? inMCF-7 breast cancer cells

Keywords:

Polyamines, SSAT, purvalanol, PPAR?, NF?B,

PDF

___

Agbottah E, Yeh WI, Berro R, Klase Z, Pedati C, Kehn-Hall K, Wu W, Kashanchi F (2008). Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways. AIDS Res Ther 5: 12.
Agostinelli E, Seiler N (2007). Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review). Int J Oncol 31: 473–484.
Arisan ED, Coker A, Palavan-Unsal N (2011). Polyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cells. Amino Acids 42: 655–665.
Arisan ED, Coker A, Palavan-Unsal N (2012). Polyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cells. Amino Acids 42: 655–665.
Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, Fakhrudin N, Ladurner A, Malainer C, Vuorinen A et al. (2013). Honokiol: a non-adipogenic PPARgamma agonist from nature. Biochim Biophys Acta 1830: 4813–4819.
Babbar N, Gerner EW, Casero RA Jr (2006). Induction of spermidine/ spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 394: 317–324.
Babbar N, Ignatenko NA, Casero RA Jr, Gerner EW (2003). Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem 278: 47762–47775.
Baeuerle PA, Baltimore D (1988). Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF- kappa B transcription factor. Cell 53: 211–217.
Basseres DS, Baldwin AS (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817–6830.
Casero RA Jr, Wang Y, Stewart TM, Devereux W, Hacker A, Wang Y, Smith R, Woster PM (2003). The role of polyamine catabolism in anti-tumour drug response. Biochem Soc Trans 31: 361–365.
Chen L, He Y, Huang H, Liao H, Wei W (2008). Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. Med Oncol 25: 161–171.
Chu PJ, Saito H, Abe K (1994). Polyamines promote neurite elongation of cultured rat hippocampal neurons. Neurosci Res 19: 155–160.
Coker A, Arisan ED, Palavan-Unsal N (2012). Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells. Mol Med Rep 5: 1037–1042.
Coker A, Arisan ED, Palavan-Unsal N (2013). Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells. Mol Med Rep 5: 1037–1042.
Eisenberg T, Knauer H, Schauer A, Buttner S, Ruckenstuhl C, Carmona-Gutierrez D, Ring J, Schroeder S, Magnes C, Antonacci L et al. (2009). Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 11: 1305–1314.
Hirano S, Haruki M, Takano K, Imanaka T, Morikawa M, Kanaya S (2006). Gene cloning and in vivo characterization of a dibenzothiophene dioxygenase from Xanthobacter polyaromaticivorans. Appl Microbiol Biotechnol 69: 672–681.
Huang Y, Pledgie A, Rubin E, Marton LJ, Woster PM, Sukumar S, Casero RA Jr, Davidson NE (2005). Role of p53/p21(Waf1/ Cip1) in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells. Cancer Biol Ther 4: 1006–1013.
Karakaş HE, Gözüaçık D (2014). Autophagy and cancer. Turk J Biol 38: 720–739.
Maccarrone M, Meloni C, Manca-di-Villahermosa S, Cococcetta N, Casciani CU, Finazzi-Agro A, Taccone-Gallucci M (2001). Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Am J Kidney Dis 37: 964–969.
Moffatt J, Hashimoto M, Kojima A, Kennedy DO, Murakami A, Koshimizu K, Ohigashi H, Matsui-Yuasa I (2000). Apoptosis induced by 1’-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation. Carcinogenesis 21: 2151–2157.
Murray-Stewart T, Applegren NB, Devereux W, Hacker A, Smith R, Wang Y, Casero RA Jr (2003). Spermidine/spermine N1- acetyltransferase (SSAT) activity in human small-cell lung carcinoma cells following transfection with a genomic SSAT construct. Biochem J 373: 629–634.
Naredi P, Hafstrom L, Zachrisson H, Rudenstam CM, Lundholm K (1994). Whole body energy expenditure protein breakdown and polyamine excretion during high dose treatment with interleukin-2 and interferon-alpha. Eur J Surg 160: 67–75.
Obakan P, Arisan ED, Calcabrini A, Agostinelli E, Bolkent S, Palavan-Unsal N (2014). Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide- induced apoptosis in LNCaP and DU145 prostate cancer cell lines. Amino Acids 46: 553–564.
Obakan P, Arisan ED, Ozfiliz P, Coker-Gurkan A, Palavan-Unsal N (2013). Purvalanol A is a strong apoptotic inducer via activating polyamine catabolic pathway in MCF-7 estrogen receptor positive breast cancer cells. Mol Biol Rep 41: 145–154.
Obakan P, Alkurt G, Köse B, Çoker Gürkan A, Arısan ED, Unsal ZN (2014). Downregulation of c-Myc mediated ODC expression after purvalanol treatment is under control of upstream MAPK signaling axis in MCF-7 breast cancer cells. Turk J Biol 38: 867–879.
Schiller M, Blank N, Heyder P, Herrmann M, Gaipl US, Kalden JR, Lorenz HM (2005). Induction of apoptosis by spermine- metabolites in primary human blood cells and various tumor cell lines. Apoptosis 10: 1151–1162.
Sethi G, Sung B, Aggarwal BB (2008). Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 233: 21–31.
Shah N, Thomas TJ, Lewis JS, Klinge CM, Shirahata A, Gelinas C, Thomas T (2001). Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene 20: 1715–1729.
Simoneau AR, Gerner EW, Phung M, McLaren CE, Meyskens FL Jr (2001). Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. J Natl Cancer Inst 93: 57–59.
Singh RP, Saxena JK, Ghatak S, Shukla OP, Wittich RM, Walter RD (1989). Polyamine metabolism in Setaria cervi, the bovine filarial worm. Parasitol Res 75: 311–315.
Villerbu N, Gaben AM, Redeuilh G, Mester J (2002). Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities. Int J Cancer 97: 761–769.
Wesierska-Gadek J, Gueorguieva M, Wojciechowski J, Horky M (2004). Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine. Pol J Pharmacol 56: 635–641.
Yadav VR, Prasad S, Sung B, Aggarwal BB (2010). The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer. Int Immunopharmacol 11: 295–309.
Zahedi K, Wang Z, Barone S, Prada AE, Kelly CN, Casero RA, Yokota N, Porter CW, Rabb H, Soleimani M (2003). Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 284: F1046–1055.